Cystic fibrosis related liver disease and endocrine considerations.

Sherwood, Jordan S; Ullal, Jagdeesh; Kutney, Katherine; Hughan, Kara S

Sherwood, Jordan S; Ullal, Jagdeesh; Kutney, Katherine; Hughan, Kara S.

Afiliação

Sherwood JS; Department of Pediatrics, Diabetes Research Center, Division of Pediatric Endocrinology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114, United States.
Ullal J; Department of Medicine, UPMC Center for Diabetes and Endocrinology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States.
Kutney K; Department of Pediatrics, Case Western Reserve University, Cleveland, OH 44106, United States.
Hughan KS; Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, United States.

J Clin Transl Endocrinol ; 27: 100283, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35024343

Palavras-chave

APRI, aspartate aminotransferase to platelet ratio; BMI, body mass index; CFBD, CF bone disease; CFLD, Cystic fibrosis-liver disease; CFRD, CF related diabetes; CFTR, cystic fibrosis transmembrane conductance regulator; Cirrhosis; Cystic fibrosis liver disease; Cystic fibrosis-related diabetes; FFA, free fatty acids; Fib-4, Fibrosis-4; GH, growth hormone; IGF-1, insulin-like growth factor-1; Insulin resistance; UDCA, ursodeoxycholic acid; ULN, upper limit of normal

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Screening_studies Idioma: En Revista: J Clin Transl Endocrinol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google